SECRETED FACTORS IN CARDIAC REMODELING PROVOKE TUMORIGENESIS AND END ORGAN DAMAGE IN HEART FAILURE

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Cancer Mortality in Trials of Heart Failure With Reduced Ejection Fraction: A Systematic Review and Meta‐Analysis

Author(s): Giacomo Tini, Edoardo Bertero, Alessio Signori, Maria Pia Sormani, Christoph Maack, Rudolf A. De Boer, Marco Canepa, Pietro Ameri
Published in: Journal of the American Heart Association, Issue 9, 2024, ISSN 2047-9980
Publisher: Wiley-Blackwell
DOI: 10.1161/jaha.119.016309

Established Tumour Biomarkers Predict Cardiovascular Events and Mortality in the General Population

Author(s): Valentina Bracun, Navin Suthahar, Canxia Shi, Sanne de Wit, Wouter C. Meijers, IJsbrand T. Klip, Rudolf A. de Boer, Joseph Pierre Aboumsallem
Published in: Frontiers in Cardiovascular Medicine, Issue 8, 2021, ISSN 2297-055X
Publisher: Frontiers Media SA
DOI: 10.3389/fcvm.2021.753885

Circulating immune checkpoints predict heart failure outcomes

Author(s): Elles M. Screever, Laura I.E. Yousif, Javid J. Moslehi, Joe‐Elie Salem, Adriaan A. Voors, Herman H.W. Silljé, Rudolf A. de Boer, Wouter C. Meijers
Published in: ESC Heart Failure, Issue 10, 2025, Page(s) 2330-2337, ISSN 2055-5822
Publisher: Wiley
DOI: 10.1002/ehf2.14304

Longitudinal Changes in Circulating Ketone Body Levels in Patients With Acute Heart Failure: A Post Hoc Analysis of the EMPA-Response-AHF Trial

Author(s): S.N. Voorrips, E.M. BOORSMA, J.C. BEUSEKAMP, R.A. DE-BOER, M.A. CONNELLY, R.P.F. DULLAART, P. VAN-DER-MEER, D.J. VAN-VELDHUISEN, A.A. VOORS, K. DAMMAN, B.D. WESTENBRINK
Published in: Journal of Cardiac Failure, Issue 29, 2024, Page(s) 33-41, ISSN 1071-9164
Publisher: Churchill Livingstone
DOI: 10.1016/j.cardfail.2022.09.009

Insulin‐like growth factor binding protein 7 (IGFBP7), a link between heart failure and senescence

Author(s): Valentina Bracun, Bart van Essen, Adriaan A. Voors, Dirk J. van Veldhuisen, Kenneth Dickstein, Faiez Zannad, Marco Metra, Stefan Anker, Nilesh J. Samani, Piotr Ponikowski, Gerasimos Filippatos, John G.F. Cleland, Chim C. Lang, Leong L. Ng, Canxia Shi, Sanne de Wit, Joseph Pierre Aboumsallem, Wouter C. Meijers, IJsbrand T. Klip, Peter van der Meer, Rudolf A. de Boer
Published in: ESC Heart Failure, Issue 9, 2025, Page(s) 4167-4176, ISSN 2055-5822
Publisher: Wiley
DOI: 10.1002/ehf2.14120

Heart failure-induced microbial dysbiosis contributes to colonic tumour formation in mice

Author(s): Sanne de Wit, Lotte Geerlings, Canxia Shi, Just Dronkers, Elisabeth M Schouten, Gillian Blancke, Vanessa Andries, Tess Yntema, Wouter C Meijers, Debby P Y Koonen, Lars Vereecke, Herman H W Silljé, Joseph-Pierre Aboumsallem, Rudolf A de Boer
Published in: Cardiovascular Research, Issue 120, 2024, Page(s) 612-622, ISSN 0008-6363
Publisher: Elsevier BV
DOI: 10.1093/cvr/cvae038

Tumour biomarkers: association with heart failure outcomes

Author(s): C. Shi, H. H. van der Wal, H. H. W. Silljé, M. M. Dokter, F. van den Berg, L. Huizinga, M. Vriesema, J. Post, S. D. Anker, J. G. Cleland, L. L. Ng, N. J. Samani, K. Dickstein, F. Zannad, C. C. Lang, P. L. van Haelst, J. A. Gietema, M. Metra, P. Ameri, M. Canepa, D. J. van Veldhuisen, A. A. Voors, R. A. de Boer
Published in: Journal of Internal Medicine, Issue 288, 2023, Page(s) 207-218, ISSN 0954-6820
Publisher: Blackwell Publishing Inc.
DOI: 10.1111/joim.13053

Relative fat mass, a new index of adiposity, is strongly associated with incident heart failure: data from PREVEND

Author(s): Navin Suthahar, Laura M. G. Meems, Coenraad Withaar, Thomas M. Gorter, Lyanne M. Kieneker, Ron T. Gansevoort, Stephan J. L. Bakker, Dirk J. van Veldhuisen, Rudolf A. de Boer
Published in: Scientific Reports, Issue 12, 2022, ISSN 2045-2322
Publisher: Nature Publishing Group
DOI: 10.1038/s41598-021-02409-6

Cardiac dysfunction in cancer patients: beyond direct cardiomyocyte damage of anticancer drugs: novel cardio-oncology insights from the joint 2019 meeting of the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart

Author(s): Carlo Gabriele Tocchetti, Pietro Ameri, Rudolf A de Boer, Yuri D’Alessandra, Michele Russo, Daniela Sorriento, Michele Ciccarelli, Bernadett Kiss, Luc Bertrand, Dana Dawson, Ines Falcao-Pires, Mauro Giacca, Nazha Hamdani, Wolfgang A Linke, Manuel Mayr, Jolanda van der Velden, Serena Zacchigna, Alessandra Ghigo, Emilio Hirsch, Alexander R Lyon, Anikó Görbe, Péter Ferdinandy, Rosalinda Madonna,
Published in: Cardiovascular Research, Issue 116, 2020, Page(s) 1820-1834, ISSN 0008-6363
Publisher: Elsevier BV
DOI: 10.1093/cvr/cvaa222

Mediators of the association between albuminuria and incident cancer: the PREVEND study

Author(s): Li Luo, Priya Vart, Lyanne M Kieneker, Bert van der Vegt, Stephan J L Bakker, Eke G Gruppen, Niek F Casteleijn, Rudolf A de Boer, Navin Suthahar, Geertruida H de Bock, Joseph Pierre Aboumsallem, Ron T Gansevoort
Published in: Clinical Kidney Journal, Issue 17, 2024, ISSN 2048-8505
Publisher: Oxford University Press
DOI: 10.1093/ckj/sfad295

Mechanisms shared between cancer, heart failure, and targeted anti-cancer therapies

Author(s): Sanne de Wit, Claire Glen, Rudolf A de Boer, Ninian N Lang
Published in: Cardiovascular Research, Issue 118, 2023, Page(s) 3451-3466, ISSN 0008-6363
Publisher: Elsevier BV
DOI: 10.1093/cvr/cvac132

Evaluation of renal cancer progression in a mouse model of heart failure

Author(s): Canxia Shi, Joseph Pierre Aboumsallem, Sanne de Wit, Elisabeth Maria Schouten, Valentina Bracun, Wouter C. Meijers, Herman H.W. Silljé, Rudolf A. de Boer
Published in: Cancer Communications, Issue 41, 2023, Page(s) 796-799, ISSN 2523-3548
Publisher: Wiley
DOI: 10.1002/cac2.12185

Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study Group of the Heart Failure Association (<scp>HFA</scp>), European Society of Cardiology (<scp>ESC</scp>)

Author(s): Wouter C. Meijers, Antoni Bayes‐Genis, Alexandre Mebazaa, Johann Bauersachs, John G.F. Cleland, Andrew J.S. Coats, James L. Januzzi, Alan S. Maisel, Kenneth McDonald, Thomas Mueller, A. Mark Richards, Petar Seferovic, Christian Mueller, Rudolf A. de Boer
Published in: European Journal of Heart Failure, Issue 23, 2023, Page(s) 1610-1632, ISSN 1388-9842
Publisher: Elsevier BV
DOI: 10.1002/ejhf.2346

Phospholamban antisense oligonucleotides improve cardiac function in murine cardiomyopathy

Author(s): Niels Grote Beverborg, Daniela Später, Ralph Knöll, Alejandro Hidalgo, Steve T. Yeh, Zaher Elbeck, Herman H. W. Silljé, Tim R. Eijgenraam, Humam Siga, Magdalena Zurek, Malin Palmér, Susanne Pehrsson, Tamsin Albery, Nils Bomer, Martijn F. Hoes, Cornelis J. Boogerd, Michael Frisk, Eva van Rooij, Sagar Damle, William E. Louch, Qing-Dong Wang, Regina Fritsche-Danielson, Kenneth R. Chien, Kenny M.
Published in: Nature Communications, Issue 12, 2022, ISSN 2041-1723
Publisher: Nature Publishing Group
DOI: 10.1038/s41467-021-25439-0

Author(s): Navin Suthahar, Laura M.G. Meems, Jennifer E. Ho, Rudolf A. de Boer
Published in: European Journal of Heart Failure, Issue 22, 2023, Page(s) 775-788, ISSN 1388-9842
Publisher: Elsevier BV
DOI: 10.1002/ejhf.1771

The effects of liraglutide and dapagliflozin on cardiac function and structure in a multi-hit mouse model of heart failure with preserved ejection fraction

Author(s): Coenraad Withaar, Laura M G Meems, George Markousis-Mavrogenis, Cornelis J Boogerd, Herman H W Silljé, Elisabeth M Schouten, Martin M Dokter, Adriaan A Voors, B Daan Westenbrink, Carolyn S P Lam, Rudolf A de Boer
Published in: Cardiovascular Research, Issue 117, 2022, Page(s) 2108-2124, ISSN 0008-6363
Publisher: Elsevier BV
DOI: 10.1093/cvr/cvaa256

A Kinase Interacting Protein 1 (AKIP1) promotes cardiomyocyte elongation and physiological cardiac remodelling

Author(s): Kirsten T. Nijholt, Pablo I. Sánchez-Aguilera, Harmen G. Booij, Silke U. Oberdorf-Maass, Martin M. Dokter, Anouk H. G. Wolters, Ben N. G. Giepmans, Wiek H. van Gilst, Joan H. Brown, Rudolf A. de Boer, Herman H. W. Silljé, B. Daan Westenbrink
Published in: Scientific Reports, Issue 13, 2023, ISSN 2045-2322
Publisher: Nature Publishing Group
DOI: 10.1038/s41598-023-30514-1

Comorbidities complicating heart failure: changes over the last 15 years

Author(s): Elles M. Screever, Martje H. L. van der Wal, Dirk J. van Veldhuisen, Tiny Jaarsma, Astrid Koops, Kuna S. van Dijk, Janke Warink-Riemersma, Jenifer E. Coster, B. Daan Westenbrink, Peter van der Meer, Rudolf A. de Boer, Wouter C. Meijers
Published in: Clinical Research in Cardiology, Issue 112, 2023, Page(s) 123-133, ISSN 1861-0684
Publisher: Steinkopff
DOI: 10.1007/s00392-022-02076-1

Divergent effects of myostatin inhibition on cardiac and skeletal muscles in a mouse model of pressure overload

Author(s): Canxia Shi, Sietske N. Zijlstra, Sanne de Wit, Wouter C. Meijers, Joseph Pierre Aboumsallem, Herman H. W. Silljé, Rudolf A. de Boer
Published in: American Journal of Physiology-Heart and Circulatory Physiology, Issue 325, 2023, Page(s) H195-H201, ISSN 0363-6135
Publisher: American Physiological Society
DOI: 10.1152/ajpheart.00223.2023

Pectins from various sources inhibit galectin-3-related cardiac fibrosis

Author(s): Carolin Pozder geb. Gehlken, A. Rogier van der Velde, Wouter C. Meijers, Herman H.W. Silljé, Pieter Muntendam, Martin M. Dokter, Wiek H. van Gilst, Henk A. Schols, Rudolf A. de Boer
Published in: Current Research in Translational Medicine, Issue 70, 2022, Page(s) 103321, ISSN 2452-3186
Publisher: Elsevier BV
DOI: 10.1016/j.retram.2021.103321

Sex-specific aspects of phospholamban cardiomyopathy: The importance and prognostic value of low-voltage electrocardiograms

Author(s): Remco de Brouwer, Laura M.G. Meems, Tom E. Verstraelen, Belend Mahmoud, Virginnio Proost, Arthur A.M. Wilde, Laurens P. Bosman, Esmée van Drie, Paul A. van der Zwaag, J. Peter van Tintelen, Arjan C. Houweling, Maarten P. van den Berg, Rudolf A. de Boer
Published in: Heart Rhythm, Issue 19, 2023, Page(s) 427-434, ISSN 1547-5271
Publisher: Elsevier BV
DOI: 10.1016/j.hrthm.2021.11.009

The role of immune checkpoints in cardiovascular disease

Author(s): Laura I. Yousif, Anniek A. Tanja, Rudolf A. de Boer, Arco J. Teske, Wouter C. Meijers
Published in: Frontiers in Pharmacology, Issue 13, 2022, ISSN 1663-9812
Publisher: Frontiers Media S.A.
DOI: 10.3389/fphar.2022.989431

Urinary potassium excretion and mortality risk in community-dwelling individuals with and without obesity

Author(s): Stanley MH Yeung, Anne Nooteboom, Ewout J Hoorn, Joris I Rotmans, Liffert Vogt, Rudolf A de Boer, Ron T Gansevoort, Gerjan Navis, Stephan JL Bakker, Martin H De Borst
Published in: The American Journal of Clinical Nutrition, Issue 116, 2023, Page(s) 741-749, ISSN 0002-9165
Publisher: American Society for Clinical Nutrition, Inc.
DOI: 10.1093/ajcn/nqac137

Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the <scp>C</scp>ardio‐<scp>O</scp>ncology <scp>S</scp>tudy <scp>G</scp>roup of the <scp>H</scp>eart <scp>F</scp>ailure <scp>A</scp>ssociation of the <scp>E</scp>uropean <scp>S</scp>ociety of <scp>C</scp>ardiology in collaboration wi

Author(s): Alexander R. Lyon, Susan Dent, Susannah Stanway, Helena Earl, Christine Brezden‐Masley, Alain Cohen‐Solal, Carlo G. Tocchetti, Javid J. Moslehi, John D. Groarke, Jutta Bergler‐Klein, Vincent Khoo, Li Ling Tan, Markus S. Anker, Stephan von Haehling, Christoph Maack, Radek Pudil, Ana Barac, Paaladinesh Thavendiranathan, Bonnie Ky, Tomas G. Neilan, Yury Belenkov, Stuart D. Rosen, Zaza Iakobishv
Published in: European Journal of Heart Failure, Issue 22, 2023, Page(s) 1945-1960, ISSN 1388-9842
Publisher: Elsevier BV
DOI: 10.1002/ejhf.1920

Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: from molecular mechanisms to therapeutic targets. A position paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC)

Author(s): Rudolf A. de Boer, Stephane Heymans, Johannes Backs, Lucie Carrier, Andrew J.S. Coats, Stefanie Dimmeler, Thomas Eschenhagen, Gerasimos Filippatos, Lior Gepstein, Jean‐Sebastien Hulot, Ralph Knöll, Christian Kupatt, Wolfgang A. Linke, Christine E. Seidman, C. Gabriele Tocchetti, Jolanda van der Velden, Roddy Walsh, Petar M. Seferovic, Thomas Thum
Published in: European Journal of Heart Failure, Issue 24, 2023, Page(s) 406-420, ISSN 1388-9842
Publisher: Elsevier BV
DOI: 10.1002/ejhf.2414

Protein Aggregation Is an Early Manifestation of Phospholamban p.(Arg14del)–Related Cardiomyopathy: Development of PLN-R14del–Related Cardiomyopathy

Author(s): Tim R. Eijgenraam, Cornelis J. Boogerd, Nienke M. Stege, Vivian Oliveira Nunes Teixeira, Martin M. Dokter, Lukas E. Schmidt, Xiaoke Yin, Konstantinos Theofilatos, Manuel Mayr, Peter van der Meer, Eva van Rooij, Jolanda van der Velden, Herman H.W. Silljé, Rudolf A. de Boer
Published in: Circulation: Heart Failure, Issue 14, 2024, ISSN 1941-3297
Publisher: Lippincott Williams & Wilkins Ltd.
DOI: 10.1161/circheartfailure.121.008532

DWORF Extends Life Span in a PLN-R14del Cardiomyopathy Mouse Model by Reducing Abnormal Sarcoplasmic Reticulum Clusters

Author(s): Nienke M. Stege, Tim R. Eijgenraam, Vivian Oliveira Nunes Teixeira, Anna M. Feringa, Elisabeth M. Schouten, Diederik W.D. Kuster, Jolanda van der Velden, Anouk H.G. Wolters, Ben N.G. Giepmans, Catherine A. Makarewich, Rhonda Bassel-Duby, Eric N. Olson, Rudolf A. de Boer, Herman H.W. Silljé
Published in: Circulation Research, Issue 133, 2024, Page(s) 1006-1021, ISSN 0009-7330
Publisher: Lippincott Williams & Wilkins Ltd.
DOI: 10.1161/circresaha.123.323304

Atrial fibrillation detected at screening is not a benign condition: outcomes in screen-detected versus clinically detected atrial fibrillation. Results from the Prevention of Renal and Vascular End-stage Disease (PREVEND) study

Author(s): Victor W Zwartkruis, Bastiaan Geelhoed, Navin Suthahar, Stephan J L Bakker, Ron T Gansevoort, Isabelle C van Gelder, Rudolf A de Boer, Michiel Rienstra
Published in: Open Heart, Issue 8, 2024, Page(s) e001786, ISSN 2053-3624
Publisher: BMJ
DOI: 10.1136/openhrt-2021-001786

Multimarker profiling identifies protective and harmful immune processes in heart failure: findings from BIOSTAT-CHF

Author(s): George Markousis-Mavrogenis, Jasper Tromp, Wouter Ouwerkerk, João Pedro Ferreira, Stefan D Anker, John G Cleland, Kenneth Dickstein, Gerasimos Filippatos, Chim C Lang, Marco Metra, Nilesh J Samani, null null, Rudolf A de Boer, Dirk J van Veldhuisen, Adriaan A Voors, Peter van der Meer
Published in: Cardiovascular Research, Issue 118, 2022, Page(s) 1964-1977, ISSN 0008-6363
Publisher: Elsevier BV
DOI: 10.1093/cvr/cvab235

Diagnostic yield of a proactive strategy for early detection of cardiovascular disease versus usual care in adults with type 2 diabetes or chronic obstructive pulmonary disease in primary care in the Netherlands (RED-CVD): a multicentre, pragmatic, cluster-randomised, controlled trial

Author(s): Amy Groenewegen, Victor W Zwartkruis, Michiel Rienstra, Nicolaas P A Zuithoff, Monika Hollander, Hendrik Koffijberg, Martijn Oude Wolcherink, Maarten J Cramer, Yvonne T van der Schouw, Arno W Hoes, Frans H Rutten, Rudolf A de Boer
Published in: The Lancet Public Health, Issue 9, 2024, Page(s) e88-e99, ISSN 2468-2667
Publisher: Elsevier BV
DOI: 10.1016/s2468-2667(23)00269-4

Proactive screening for symptoms: A simple method to improve early detection of unrecognized cardiovascular disease in primary care. Results from the Lifelines Cohort Study

Author(s): Victor W. Zwartkruis, Amy Groenewegen, Frans H. Rutten, Monika Hollander, Arno W. Hoes, M. Yldau van der Ende, Pim van der Harst, Maarten Jan Cramer, Yvonne T. van der Schouw, Hendrik Koffijberg, Michiel Rienstra, Rudolf A. de Boer
Published in: Preventive Medicine, Issue 138, 2022, Page(s) 106143, ISSN 0091-7435
Publisher: Academic Press
DOI: 10.1016/j.ypmed.2020.106143

Heart failure with preserved ejection fraction in humans and mice: embracing clinical complexity in mouse models

Author(s): Coenraad Withaar, Carolyn S P Lam, Gabriele G Schiattarella, Rudolf A de Boer, Laura M G Meems
Published in: European Heart Journal, Issue 42, 2022, Page(s) 4420-4430, ISSN 0195-668X
Publisher: Oxford University Press
DOI: 10.1093/eurheartj/ehab389

Sex differences in associations of comorbidities with incident cardiovascular disease: focus on absolute risk

Author(s): Just Dronkers, Laura M G Meems, Dirk J van Veldhuisen, Sven Meyer, Lyanne M Kieneker, Ron T Gansevoort, Stephan J L Bakker, Michiel Rienstra, Rudolf A de Boer, Navin Suthahar
Published in: European Heart Journal Open, Issue 2, 2022, ISSN 2752-4191
Publisher: Oxford University Press (OUP)
DOI: 10.1093/ehjopen/oeac017

Multi-omics analyses identify molecular signatures with prognostic values in different heart failure aetiologies

Author(s): Joseph Pierre Aboumsallem, Canxia Shi, Sanne De Wit, George Markousis-Mavrogenis, Valentina Bracun, Tim R. Eijgenraam, Martijn F. Hoes, Wouter C. Meijers, Elles M. Screever, Marloes E. Schouten, Adriaan A. Voors, Herman H.W. Silljé, Rudolf A. De Boer
Published in: Journal of Molecular and Cellular Cardiology, Issue 175, 2024, Page(s) 13-28, ISSN 0022-2828
Publisher: Academic Press
DOI: 10.1016/j.yjmcc.2022.12.001

Clonal haematopoiesis of indeterminate potential: associations with heart failure incidence, clinical parameters and biomarkers

Author(s): Canxia Shi, Joseph Pierre Aboumsallem, Navin Suthahar, Aniek O. de Graaf, Joop H. Jansen, Isabelle A. van Zeventer, Valentina Bracun, Sanne de Wit, Elles M. Screever, Pieter F. van den Berg, Wouter C. Meijers, Ron T. Gansevoort, Stephan J.L. Bakker, Pim van der Harst, Herman H.W. Silljé, Gerwin Huls, Rudolf A. de Boer
Published in: European Journal of Heart Failure, Issue 25, 2024, Page(s) 4-13, ISSN 1388-9842
Publisher: Elsevier BV
DOI: 10.1002/ejhf.2715

Troponins and natriuretic peptides to detect cardiotoxicity: useful biomarkers or paradise lost?

Author(s): Valentina Bracun, Rudolf A. de Boer
Published in: European Journal of Heart Failure, Issue 22, 2023, Page(s) 362-365, ISSN 1388-9842
Publisher: Elsevier BV
DOI: 10.1002/ejhf.1676

Exercise: a molecular tool to boost muscle growth and mitochondrial performance in heart failure?

Author(s): Kirsten T. Nijholt, Pablo I. Sánchez‐Aguilera, Suzanne N. Voorrips, Rudolf A. de Boer, B. Daan Westenbrink
Published in: European Journal of Heart Failure, Issue 24, 2023, Page(s) 287-298, ISSN 1388-9842
Publisher: Elsevier BV
DOI: 10.1002/ejhf.2407

Unbiased complexome profiling and global proteomics analysis reveals mitochondrial impairment and potential changes at the intercalated disk in presymptomatic R14Δ/+ mice hearts

Author(s): Brian Foo, Hugo Amedei, Surmeet Kaur, Samir Jaawan, Angela Boshnakovska, Tanja Gall, Rudolf A. de Boer, Herman H. W. Silljé, Henning Urlaub, Peter Rehling, Christof Lenz, Stephan E. Lehnart
Published in: PLOS ONE, Issue 19, 2024, Page(s) e0311203, ISSN 1932-6203
Publisher: Public Library of Science
DOI: 10.1371/journal.pone.0311203

Could SGLT2 Inhibitors Improve Exercise Intolerance in Chronic Heart Failure?

Author(s): Suzanne N. Voorrips, Huitzilihuitl Saucedo-Orozco, Pablo I. Sánchez-Aguilera, Rudolf A. De Boer, Peter Van der Meer, B. Daan Westenbrink
Published in: International Journal of Molecular Sciences, Issue 23, 2024, Page(s) 8631, ISSN 1422-0067
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/ijms23158631

Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the <scp>Cardio‐Oncology Study Group</scp> of the <scp>Heart Failure Association</scp> and the <scp>Cardio‐Oncology Council of the European Society of Cardiology</scp>

Author(s): Radek Pudil, Christian Mueller, Jelena Čelutkienė, Peter A. Henriksen, Dan Lenihan, Susan Dent, Ana Barac, Susanna Stanway, Javid Moslehi, Thomas M. Suter, Bonnie Ky, Martin Štěrba, Daniela Cardinale, Alain Cohen‐Solal, Carlo Gabriele Tocchetti, Dimitrios Farmakis, Jutta Bergler‐Klein, Markus S. Anker, Stephan Von Haehling, Yury Belenkov, Zaza Iakobishvili, Christoph Maack, Fortunato Ciard
Published in: European Journal of Heart Failure, Issue 22, 2023, Page(s) 1966-1983, ISSN 1388-9842
Publisher: Elsevier BV
DOI: 10.1002/ejhf.2017

The Time Has Come to Explore Plasma Biomarkers in Genetic Cardiomyopathies

Author(s): Nienke M. Stege, Rudolf A. de Boer, Maarten P. van den Berg, Herman H. W. Silljé
Published in: International Journal of Molecular Sciences, Issue 22, 2025, Page(s) 2955, ISSN 1422-0067
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/ijms22062955

Bariatric surgery and cardiovascular disease: a systematic review and meta-analysis

Author(s): Sophie L van Veldhuisen, Thomas M Gorter, Gijs van Woerden, Rudolf A de Boer, Michiel Rienstra, Eric J Hazebroek, Dirk J van Veldhuisen
Published in: European Heart Journal, Issue 43, 2022, Page(s) 1955-1969, ISSN 0195-668X
Publisher: Oxford University Press
DOI: 10.1093/eurheartj/ehac071

Galectin-3 and Blood Group: Binding Properties, Effects on Plasma Levels, and Consequences for Prognostic Performance

Author(s): Carolin Pozder, Elles M. Screever, A. Rogier van der Velde, Herman H. Silljé, Janne Suwijn, Saskia de Rond, Marcus E. Kleber, Graciela Delgado, Jan Jacob Schuringa, Wiek H. van Gilst, Wouter C. Meijers, Winfried März, Rudolf A. de Boer
Published in: International Journal of Molecular Sciences, Issue 24, 2023, Page(s) 4415, ISSN 1422-0067
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/ijms24054415

Progress in heart failure management in the Netherlands and beyond: long-term commitment to deliver high-quality research and patient care

Author(s): L. M. G. Meems, D. J. van Veldhuisen, R. A. de Boer
Published in: Netherlands Heart Journal, Issue 28, 2022, Page(s) 31-38, ISSN 1568-5888
Publisher: Mediselect B.V.
DOI: 10.1007/s12471-020-01453-7

Cardiac Biomarkers in Patients with Cancer: Considerations, Clinical Implications, and Future Avenues

Author(s): Valentina Bracun, Joseph Pierre Aboumsallem, Peter van der Meer, Rudolf A. de Boer
Published in: Current Oncology Reports, Issue 22, 2022, ISSN 1523-3790
Publisher: Current Science Inc.
DOI: 10.1007/s11912-020-00930-x

Common risk factors for heart failure and cancer

Author(s): Wouter C Meijers, Rudolf A de Boer
Published in: Cardiovascular Research, Issue 115, 2022, Page(s) 844-853, ISSN 0008-6363
Publisher: Elsevier BV
DOI: 10.1093/cvr/cvz035

Kidney Function in Patients With Neuromuscular Disease: Creatinine Versus Cystatin C

Author(s): Elles M. Screever, Jenny E. Kootstra-Ros, Joyce Doorn, Jellie A. Nieuwenhuis, Henk E. J. Meulenbelt, Wouter C. Meijers, Rudolf A. de Boer
Published in: Frontiers in Neurology, Issue 12, 2021, ISSN 1664-2295
Publisher: Frontiers Research Foundation
DOI: 10.3389/fneur.2021.688246

Cardiac remodelling – Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology

Author(s): Arantxa González, A. Mark Richards, Rudolf A. de Boer, Thomas Thum, Henrike Arfsten, Martin Hülsmann, Inês Falcao‐Pires, Javier Díez, Roger S.Y. Foo, Mark Y. Chan, Alberto Aimo, Chukwuemeka G. Anene‐Nzelu, Magdy Abdelhamid, Stamatis Adamopoulos, Stefan D. Anker, Yuri Belenkov, Tuvia Ben Gal, Alain Cohen‐Solal, Michael Böhm, Ovidiu Chioncel, Victoria Delgado, Michele Emdin, Ewa A. Jankow
Published in: European Journal of Heart Failure, Issue 24, 2023, Page(s) 927-943, ISSN 1388-9842
Publisher: Elsevier BV
DOI: 10.1002/ejhf.2493

Left atrial volume and left ventricular mass indices in heart failure with preserved and reduced ejection fraction

Author(s): Carolin Gehlken, Elles M. Screever, Navin Suthahar, Peter van der Meer, B. Daan Westenbrink, Jennifer E. Coster, Dirk J. Van Veldhuisen, Rudolf A. de Boer, Wouter C. Meijers
Published in: ESC Heart Failure, Issue 8, 2025, Page(s) 2458-2466, ISSN 2055-5822
Publisher: Wiley
DOI: 10.1002/ehf2.13366

Cancer and heart disease: associations and relations

Author(s): Rudolf A. de Boer, Wouter C. Meijers, Peter van der Meer, Dirk J. van Veldhuisen
Published in: European Journal of Heart Failure, Issue 21, 2023, Page(s) 1515-1525, ISSN 1388-9842
Publisher: Elsevier BV
DOI: 10.1002/ejhf.1539

Reverse Cardio‐Oncology: Cancer Development in Patients With Cardiovascular Disease

Author(s): Joseph Pierre Aboumsallem, Javid Moslehi, Rudolf A. de Boer
Published in: Journal of the American Heart Association, Issue 9, 2024, ISSN 2047-9980
Publisher: Wiley-Blackwell
DOI: 10.1161/jaha.119.013754

Associations of relative fat mass and BMI with all‐cause mortality: Confounding effect of muscle mass

Author(s): Navin Suthahar, Victor Zwartkruis, Bastiaan Geelhoed, Coenraad Withaar, Laura M. G. Meems, Stephan J. L. Bakker, Ron T. Gansevoort, Dirk Jan van Veldhuisen, Michiel Rienstra, Rudolf A. de Boer
Published in: Obesity, Issue 32, 2024, Page(s) 603-611, ISSN 1930-7381
Publisher: Wiley-Blackwell
DOI: 10.1002/oby.23953

Management of cardiac fibrosis is the largest unmet medical need in heart failure

Author(s): Javier Díez, Rudolf A de Boer
Published in: Cardiovascular Research, Issue 118, 2022, Page(s) e20-e22, ISSN 0008-6363
Publisher: Elsevier BV
DOI: 10.1093/cvr/cvab228

A new classification of cardio-oncology syndromes

Author(s): Rudolf A. de Boer, Joseph Pierre Aboumsallem, Valentina Bracun, Douglas Leedy, Richard Cheng, Sahishnu Patel, David Rayan, Svetlana Zaharova, Jennifer Rymer, Jennifer M. Kwan, Joshua Levenson, Claudio Ronco, Paaladinesh Thavendiranathan, Sherry-Ann Brown
Published in: Cardio-Oncology, Issue 7, 2022, ISSN 2057-3804
Publisher: Springer Science and Business Media LLC
DOI: 10.1186/s40959-021-00110-1

Reassessing the Mechanisms of PLN-R14del Cardiomyopathy

Author(s): Nienke M. Stege, Rudolf A. de Boer, Catherine A. Makarewich, Peter van der Meer, Herman H.W. Silljé
Published in: JACC: Basic to Translational Science, Issue 9, 2024, Page(s) 1041-1052, ISSN 2452-302X
Publisher: Elsevier BV
DOI: 10.1016/j.jacbts.2024.02.017

Shift work is associated with 10-year incidence of atrial fibrillation in younger but not older individuals from the general population: results from the Tromsø Study

Author(s): Victor W Zwartkruis, Ekaterina Sharashova, Tom Wilsgaard, Rudolf A de Boer, Maja-Lisa Løchen, Michiel Rienstra
Published in: Open Heart, Issue 9, 2024, Page(s) e002086, ISSN 2053-3624
Publisher: BMJ
DOI: 10.1136/openhrt-2022-002086

Being in Two Minds—The Challenge of Heart Failure with Preserved Ejection Fraction Diagnosis with a Single Biomarker

Author(s): Navin Suthahar, Carsten Tschöpe, Rudolf A de Boer
Published in: Clinical Chemistry, Issue 67, 2021, Page(s) 46-49, ISSN 0009-9147
Publisher: American Association for Clinical Chemistry, Inc.
DOI: 10.1093/clinchem/hvaa255

Associations of relative fat mass, a new index of adiposity, with type-2 diabetes in the general population

Author(s): Navin Suthahar, Kan Wang, Victor W. Zwartkruis, Stephan J.L. Bakker, Silvio E. Inzucchi, Laura M.G. Meems, Tim R. Eijgenraam, Fariba Ahmadizar, Eric G. Sijbrands, Ron T. Gansevoort, Lyanne M. Kieneker, Dirk J. van Veldhuisen, Maryam Kavousi, Rudolf A. de Boer
Published in: European Journal of Internal Medicine, Issue 109, 2024, Page(s) 73-78, ISSN 0953-6205
Publisher: Elsevier BV
DOI: 10.1016/j.ejim.2022.12.024

Preclinical Models of Cancer Therapy–Associated Cardiovascular Toxicity: A Scientific Statement From the American Heart Association

Author(s): Aarti Asnani, Javid J. Moslehi, Bishow B. Adhikari, Alan H. Baik, Andreas M. Beyer, Rudolf A. de Boer, Alessandra Ghigo, Isabella M. Grumbach, Salvia Jain, Han Zhu, null null
Published in: Circulation Research, Issue 129, 2024, ISSN 0009-7330
Publisher: Lippincott Williams & Wilkins Ltd.
DOI: 10.1161/res.0000000000000473

Exploring Cardiac Fibrosis

Author(s): Rudolf A. de Boer, Reza Ardehali
Published in: JACC: Basic to Translational Science, Issue 9, 2024, Page(s) 1023-1025, ISSN 2452-302X
Publisher: Elsevier BV
DOI: 10.1016/j.jacbts.2024.06.006

Current understanding of fibrosis in genetic cardiomyopathies

Author(s): Tim R. Eijgenraam, Herman H.W. Silljé, Rudolf A. de Boer
Published in: Trends in Cardiovascular Medicine, Issue 30, 2022, Page(s) 353-361, ISSN 1050-1738
Publisher: Elsevier BV
DOI: 10.1016/j.tcm.2019.09.003

A combined bioinformatics, experimental and clinical approach to identify novel cardiac‐specific heart failure biomarkers: is <scp>Dickkopf</scp>‐3 (<scp>DKK3</scp>) a possible candidate?

Author(s): Arnold Piek, Navin Suthahar, Adriaan A. Voors, Rudolf A. de Boer, Herman H.W. Silljé
Published in: European Journal of Heart Failure, Issue 22, 2023, Page(s) 2065-2074, ISSN 1388-9842
Publisher: Elsevier BV
DOI: 10.1002/ejhf.1988

Elevations of Cardiac Troponin in Patients Receiving Immune Checkpoint Inhibitors

Author(s): Pieter F. van den Berg, Valentina Bracun, Michel Noordman, Peter van der Meer, Canxia Shi, Sjoukje F. Oosting, Joseph Pierre Aboumsallem, Sanne de Wit, Wouter C. Meijers, Mathilde Jalving, Michel van Kruchten, Rudolf A. de Boer
Published in: JACC: Advances, Issue 3, 2025, Page(s) 101375, ISSN 2772-963X
Publisher: Elsevier BV
DOI: 10.1016/j.jacadv.2024.101375

Multiomics Analysis Provides Novel Pathways Related to Progression of Heart Failure

Author(s): Wouter Ouwerkerk, Joao P. Belo Pereira, Troy Maasland, Johanna E. Emmens, Sylwia M. Figarska, Jasper Tromp, Andrea L. Koekemoer, Christopher P. Nelson, Mintu Nath, Simon P.R. Romaine, John G.F. Cleland, Faiez Zannad, Dirk J. van Veldhuisen, Chim C. Lang, Piotr Ponikowski, Gerasimos Filippatos, Stefan Anker, Marco Metra, Kenneth Dickstein, Leong L. Ng, Rudolf A. de Boer, Natal van Riel, Max Nieuwdo
Published in: Journal of the American College of Cardiology, Issue 82, 2024, Page(s) 1921-1931, ISSN 0735-1097
Publisher: Elsevier BV
DOI: 10.1016/j.jacc.2023.08.053

Screening for Heart Failure: Biomarkers to Detect Heightened Risk in the General Population

Author(s): Leah B. Kosyakovsky, Rudolf A. de Boer, Jennifer E. Ho
Published in: Current Heart Failure Reports, Issue 21, 2024, Page(s) 591-603, ISSN 1546-9530
Publisher: Current Science Inc.
DOI: 10.1007/s11897-024-00686-6

Relationship between body mass index, cardiovascular biomarkers and incident heart failure

Author(s): Navin Suthahar, Laura M.G. Meems, Dion Groothof, Stephan J.L. Bakker, Ron T. Gansevoort, Dirk J. van Veldhuisen, Rudolf A. de Boer
Published in: European Journal of Heart Failure, Issue 23, 2023, Page(s) 396-402, ISSN 1388-9842
Publisher: Elsevier BV
DOI: 10.1002/ejhf.2102

A randomized controlled trial of eplerenone in asymptomatic phospholamban p.Arg14del carriers

Author(s): Remco de Brouwer, Wouter P te Rijdt, Edgar T Hoorntje, Ahmad Amin, Folkert W Asselbergs, Moniek G P J Cox, Jeroen F van der Heijden, Hans Hillege, Jacco C Karper, Belend Mahmoud, Peter van der Meer, Anton Oomen, Anneline S J M te Riele, Herman H W Silljé, Hanno L Tan, Jan Peter van Tintelen, Dirk J van Veldhuisen, Berend Daan Westenbrink, Ans C P Wiesfeld, Tineke P Willems, Paul A van der Zwaag,
Published in: European Heart Journal, Issue 44, 2023, Page(s) 4284-4287, ISSN 0195-668X
Publisher: Oxford University Press
DOI: 10.1093/eurheartj/ehad292

Sex-specific risk factors for new-onset heart failure: the PREVEND study at 25 years

Author(s): Bart J van Essen, Johanna E Emmens, Jasper Tromp, Wouter Ouwerkerk, Marcelle D Smit, Christiane A Geluk, Lukas Baumhove, Navin Suthahar, Ron T Gansevoort, Stephan J L Bakker, Kevin Damman, Peter van der Meer, Rudolf A de Boer, Dirk J van Veldhuisen, Adriaan A Voors
Published in: European Heart Journal, Issue 46, 2025, Page(s) 1528-1536, ISSN 0195-668X
Publisher: Oxford University Press
DOI: 10.1093/eurheartj/ehae868

Cardio-onco-metabolism: metabolic remodelling in cardiovascular disease and cancer

Author(s): Anja Karlstaedt, Javid Moslehi, Rudolf A. de Boer
Published in: Nature Reviews Cardiology, Issue 19, 2022, Page(s) 414-425, ISSN 1759-5002
Publisher: Nature Publishing Group
DOI: 10.1038/s41569-022-00698-6

High-Sensitivity Troponin-T and Cardiovascular Outcomes in the Community: Differences Between Women and Men

Author(s): Navin Suthahar, Laura M.G. Meems, Dirk J. van Veldhuisen, Joan E. Walter, Ron T. Gansevoort, Stephane Heymans, Blanche Schroen, Pim van der Harst, Jenny E. Kootstra-Ros, Vanessa van Empel, Christian Mueller, Stephan J.L. Bakker, Rudolf A. de Boer
Published in: Mayo Clinic Proceedings, Issue 95, 2022, Page(s) 1158-1168, ISSN 0025-6196
Publisher: Mayo Medical Ventures
DOI: 10.1016/j.mayocp.2020.01.017

Distinct pathophysiological pathways in women and men with heart failure

Author(s): Alice Ravera, Bernadet T. Santema, Rudolf A. de Boer, Stefan D. Anker, Nilesh J. Samani, Chim C. Lang, Leong Ng, John G.F. Cleland, Kenneth Dickstein, Carolyn S.P. Lam, Harriette G. C. Van Spall, Gerasimos Filippatos, Dirk J. van Veldhuisen, Marco Metra, Adriaan A. Voors, Iziah E. Sama
Published in: European Journal of Heart Failure, Issue 24, 2023, Page(s) 1532-1544, ISSN 1388-9842
Publisher: Elsevier BV
DOI: 10.1002/ejhf.2534

Heart failure pharmacotherapy and cancer: pathways and pre-clinical/clinical evidence

Author(s): Nabil V Sayour, Ágnes M Paál, Pietro Ameri, Wouter C Meijers, Giorgio Minotti, Ioanna Andreadou, Antonella Lombardo, Massimiliano Camilli, Heinz Drexel, Erik Lerkevang Grove, Gheorghe Andrei Dan, Andreea Ivanescu, Anne Grete Semb, Gianluigi Savarese, Dobromir Dobrev, Filippo Crea, Juan-Carlos Kaski, Rudolf A de Boer, Péter Ferdinandy, Zoltán V Varga
Published in: European Heart Journal, Issue 45, 2024, Page(s) 1224-1240, ISSN 0195-668X
Publisher: Oxford University Press
DOI: 10.1093/eurheartj/ehae105

Challenges in the diagnosis of heart failure with preserved ejection fraction in individuals with obesity

Author(s): Bas M. van Dalen, Jie Fen Chin, Praveen A. Motiram, Anneke Hendrix, Mireille E. Emans, Jasper J. Brugts, B. Daan Westenbrink, Rudolf A. de Boer
Published in: Cardiovascular Diabetology, Issue 24, 2025, ISSN 1475-2840
Publisher: BioMed Central
DOI: 10.1186/s12933-025-02612-z

Diagnostic role of echocardiography for patients with heart failure symptoms and preserved left ventricular ejection fraction

Author(s): A. Hagendorff, S. Stöbe, J. Kandels, R. de Boer, C. Tschöpe
Published in: Herz, Issue 47, 2022, Page(s) 293-300, ISSN 0340-9937
Publisher: Urban und Vogel Medien und Medizin Verlagsgesellschaft mbH
DOI: 10.1007/s00059-022-05118-6

Circulating bone morphogenetic protein 10 as a novel marker of atrial stress and remodelling in heart failure

Author(s): Daan C H Ceelen, Valentina Bracun, Bart J van Essen, Adriaan A Voors, Rudolf A de Boer, Jozine M ter Maaten, Serge Masson, Peter Kastner, Chim C Lang, Navin Suthahar
Published in: Heart, Issue 111, 2025, Page(s) 172-179, ISSN 1355-6037
Publisher: BMJ Publishing Group
DOI: 10.1136/heartjnl-2024-324486

Multifactorial Diseases of the Heart, Kidneys, Lungs, and Liver and Incident Cancer: Epidemiology and Shared Mechanisms

Author(s): Canxia Shi, Sanne de Wit, Emina Učambarlić, George Markousis-Mavrogenis, Elles Screever, Wouter Meijers, Rudolf de Boer, Joseph Aboumsallem
Published in: Cancers, Issue 15, 2025, Page(s) 729, ISSN 2072-6694
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/cancers15030729

A Kinase Interacting Protein 1 regulates mitochondrial protein levels in energy metabolism and promotes mitochondrial turnover after exercise

Author(s): Kirsten T. Nijholt, Pablo I. Sánchez-Aguilera, Belend Mahmoud, Albert Gerding, Justina C. Wolters, Anouk H. G. Wolters, Ben N. G. Giepmans, Herman H. W. Silljé, Rudolf A. de Boer, Barbara M. Bakker, B. Daan Westenbrink
Published in: Scientific Reports, Issue 13, 2023, ISSN 2045-2322
Publisher: Nature Publishing Group
DOI: 10.1038/s41598-023-45961-z

The emerging plasma biomarker Dickkopf-3 (DKK3) and its association with renal and cardiovascular disease in the general population

Author(s): Arnold Piek, Leonie Smit, Navin Suthahar, Stephan J. L. Bakker, Rudolf A. de Boer, Herman H. W. Silljé
Published in: Scientific Reports, Issue 11, 2022, ISSN 2045-2322
Publisher: Nature Publishing Group
DOI: 10.1038/s41598-021-88107-9

Risk Factors for Immune Checkpoint Inhibitor–Mediated Cardiovascular Toxicities

Author(s): Laura I. Yousif, Elles M. Screever, Daniëlle Versluis, Joseph Pierre Aboumsallem, Stefan Nierkens, Olivier C. Manintveld, Rudolf A. de Boer, Wouter C. Meijers
Published in: Current Oncology Reports, Issue 25, 2023, Page(s) 753-763, ISSN 1523-3790
Publisher: Current Science Inc.
DOI: 10.1007/s11912-023-01414-4

Antisense Therapy Attenuates Phospholamban p.(Arg14del) Cardiomyopathy in Mice and Reverses Protein Aggregation

Author(s): Tim R. Eijgenraam, Nienke M. Stege, Vivian Oliveira Nunes Teixeira, Remco de Brouwer, Elisabeth M. Schouten, Niels Grote Beverborg, Liu Sun, Daniela Später, Ralph Knöll, Kenny M. Hansson, Carl Amilon, David Janzén, Steve T. Yeh, Adam E. Mullick, Peter van der Meer, Rudolf A. de Boer, Herman H. W. Silljé
Published in: International Journal of Molecular Sciences, Issue 23, 2024, Page(s) 2427, ISSN 1422-0067
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/ijms23052427

Relative fat mass and prediction of incident atrial fibrillation, heart failure and coronary artery disease in the general population

Author(s): Victor W. Zwartkruis, Navin Suthahar, Demy L. Idema, Belend Mahmoud, Colinda van Deutekom, Frans H. Rutten, Yvonne T. van der Schouw, Michiel Rienstra, Rudolf A. de Boer
Published in: International Journal of Obesity, Issue 47, 2023, Page(s) 1256-1262, ISSN 0307-0565
Publisher: Nature Publishing Group
DOI: 10.1038/s41366-023-01380-8

Fibrotic Marker Galectin-3 Identifies Males at Risk of Developing Cancer and Heart Failure

Author(s): Pieter F. van den Berg, Joseph Pierre Aboumsallem, Elles M. Screever, Canxia Shi, Sanne de Wit, Valentina Bracun, Laura I. Yousif, Lotte Geerlings, Dongyu Wang, Jennifer E. Ho, Stephan J.L. Bakker, Bert van der Vegt, Herman H.W. Silljé, Rudolf A. de Boer, Wouter C. Meijers
Published in: JACC: CardioOncology, Issue 5, 2023, Page(s) 445-453, ISSN 2666-0873
Publisher: Elsevier BV
DOI: 10.1016/j.jaccao.2023.03.015

Large-scale genome-wide association analyses identify novel genetic loci and mechanisms in hypertrophic cardiomyopathy

Author(s): Rafik Tadros, Sean L. Zheng, Christopher Grace, Paloma Jordà, Catherine Francis, Dominique M. West, Sean J. Jurgens, Kate L. Thomson, Andrew R. Harper, Elizabeth Ormondroyd, Xiao Xu, Pantazis I. Theotokis, Rachel J. Buchan, Kathryn A. McGurk, Francesco Mazzarotto, Beatrice Boschi, Elisabetta Pelo, Michael Lee, Michela Noseda, Amanda Varnava, Alexa M. C. Vermeer, Roddy Walsh, Ahmad S. Amin, Marjon
Published in: Nature Genetics, Issue 57, 2025, Page(s) 530-538, ISSN 1061-4036
Publisher: Nature Publishing Group
DOI: 10.1038/s41588-025-02087-4

An increase in albuminuria is associated with a higher incidence of malignancies

Author(s): Li Luo, Lyanne M Kieneker, Yuanhang Yang, Roemer J Janse, Alessandro Bosi, Rudolf A de Boer, Priya Vart, Juan-Jesus Carrero, Ron T Gansevoort
Published in: Clinical Kidney Journal, Issue 17, 2024, ISSN 2048-8505
Publisher: Oxford University Press
DOI: 10.1093/ckj/sfae009

Pathophysiological pathways related to high plasma growth differentiation factor 15 concentrations in patients with heart failure

Author(s): Daan Ceelen, Adriaan A. Voors, Jasper Tromp, Dirk J. van Veldhuisen, Kenneth Dickstein, Rudolf A. de Boer, Chim C. Lang, Stefan D. Anker, Leong L. Ng, Marco Metra, Piotr Ponikowski, Sylwia M. Figarska
Published in: European Journal of Heart Failure, Issue 24, 2023, Page(s) 308-320, ISSN 1388-9842
Publisher: Elsevier BV
DOI: 10.1002/ejhf.2424

Hallmarks of cancer in patients with heart failure: data from BIOSTAT-CHF

Author(s): P. F. van den Berg, L. I. Yousif, G. Markousis-Mavrogenis, C. Shi, V. Bracun, J. Tromp, S. de Wit, Y. Appels, E. M. Screever, J. P. Aboumsallem, W. Ouwerkerk, D. J. van Veldhuisen, H. H. W. Silljé, A. A. Voors, R. A. de Boer, Wouter C. Meijers
Published in: Cardio-Oncology, Issue 10, 2024, ISSN 2057-3804
Publisher: Springer Science and Business Media LLC
DOI: 10.1186/s40959-024-00246-w

Atrial disease and heart failure: the common soil hypothesis proposed by the Heart Failure Association of the European Society of Cardiology

Author(s): Andrew J S Coats, Stephane Heymans, Dimitrios Farmakis, Stefan D Anker, Johannes Backs, Johann Bauersachs, Rudolf A de Boer, Jelena Čelutkienė, John G F Cleland, Dobromir Dobrev, Isabelle C van Gelder, Stephan von Haehling, Gerhard Hindricks, Ewa Jankowska, Dipak Kotecha, Linda W van Laake, Mitja Lainscak, Lars H Lund, Ida Gjervold Lunde, Alexander R Lyon, Aristomenis Manouras, Davor Miličić,
Published in: European Heart Journal, Issue 43, 2022, Page(s) 863-867, ISSN 0195-668X
Publisher: Oxford University Press
DOI: 10.1093/eurheartj/ehab834

The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unresponsive to standard heart failure therapy

Author(s): Tim R. Eijgenraam, Bastiaan J. Boukens, Cornelis J. Boogerd, E. Marloes Schouten, Cees W. A. van de Kolk, Nienke M. Stege, Wouter P. te Rijdt, Edgar T. Hoorntje, Paul A. van der Zwaag, Eva van Rooij, J. Peter van Tintelen, Maarten P. van den Berg, Peter van der Meer, Jolanda van der Velden, Herman H. W. Silljé, Rudolf A. de Boer
Published in: Scientific Reports, Issue 10, 2022, ISSN 2045-2322
Publisher: Nature Publishing Group
DOI: 10.1038/s41598-020-66656-9

Searching for OpenAIRE data...

Publications

Share this page Share this page on social networks

Download Download the content of the page